Terms: = Breast cancer AND PR, PGR, progesterone receptor AND Staging
324 results:
1. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
3. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq.
Hasan NA; Pity IS
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):34-39. PubMed ID: 38279496
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
7. Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select breast cancer Patients.
Khan SY; Cole J; Habrawi Z; Melkus MW; Layeequr Rahman R
Ann Surg Oncol; 2023 Dec; 30(13):8398-8403. PubMed ID: 37770723
[TBL] [Abstract] [Full Text] [Related]
8. Calcium-Sensing receptor Expression in breast cancer.
Busic-Pavlek I; Dumic-Cule I; Kovacevic L; Milosevic M; Delimar P; Korsa L; Marusic Z; Prutki M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511437
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer.
Terán S; Alva M; Tolosa P; Rey-Cárdenas M; Madariaga A; Lema L; Ruano Y; Manso L; Ciruelos E; Sánchez-Bayona R
Breast; 2023 Oct; 71():42-46. PubMed ID: 37481795
[TBL] [Abstract] [Full Text] [Related]
10. The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic staging System in Stage III ER+/HER2- breast cancer.
Wang M; Zhang M; Chen H
Adv Ther; 2023 Sep; 40(9):3912-3925. PubMed ID: 37382865
[TBL] [Abstract] [Full Text] [Related]
11. Study of risk factors and marker status in women with breast cancer in Brunei Darussalam.
Wong CB; Mustapa A; Matusin SNI; Abdullah MS; Usman AN; Haji Abdul Hamid MRW
Breast Dis; 2023; 42(1):183-189. PubMed ID: 37355881
[TBL] [Abstract] [Full Text] [Related]
12. Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study.
Jadoon SK; Soomro R; Ahsan MN; Ijaz Khan RM; Iqbal S; Yasmin F; Najeeb H; Saleem N; Cho N; Resham ; Shaikh TG; Saba Hasan SF; Khalid MZ; Alvi S; Rizvi AM; Asghar MS
Medicine (Baltimore); 2023 May; 102(20):e33811. PubMed ID: 37335707
[TBL] [Abstract] [Full Text] [Related]
13. De-Implementation of Axillary staging and Radiotherapy in Low-Risk breast cancer Patients Aged 70-79 Years from Six Italian cancer Institutes.
Bucchi L; Ravaioli A; Dal Maso L; Falcini F; Mangone L; Massarut S; Schirosi L; Crispo A; Vici P; Franceschi S
Curr Oncol; 2023 Apr; 30(4):4177-4184. PubMed ID: 37185431
[TBL] [Abstract] [Full Text] [Related]
14. Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary breast cancers and Thyroid Disease.
Li J; Liu Y; Jin J; Shi Q; Ji Y; Zhang B; Hu P
Mediators Inflamm; 2023; 2023():3133554. PubMed ID: 37152372
[TBL] [Abstract] [Full Text] [Related]
15. Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
Ma SJ; Gill J; Yendamuri K; Chatterjee U; Waldman O; Dunne-Jaffe C; Fekrmandi F; Shekher R; Iovoli A; Yao S; Oladeru OT; Singh AK
BMC Cancer; 2023 Apr; 23(1):330. PubMed ID: 37041481
[TBL] [Abstract] [Full Text] [Related]
16. The Relevance of Common K-RAS Gene Mutations and K-RAS mRNA Expression with Clinicopathological Findings and Survival in breast cancer.
Kamian S; Ashoori H; Vahidian F; Davoudi S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):909-914. PubMed ID: 36974544
[TBL] [Abstract] [Full Text] [Related]
17. Novel Prognostic staging System for Patients With De Novo Metastatic breast cancer.
Plichta JK; Thomas SM; Hayes DF; Chavez-MacGregor M; Allison K; de Los Santos J; Fowler AM; Giuliano AE; Sharma P; Smith BD; van Eycken E; Edge SB; Hortobagyi GN
J Clin Oncol; 2023 May; 41(14):2546-2560. PubMed ID: 36944149
[TBL] [Abstract] [Full Text] [Related]
18. Survival Nomogram for Patients With Locally Advanced breast cancer Undergoing Immediate breast Reconstruction: A SEER Population-Based Study.
Pan J; Peng L; Xia C; Wang A; Tong X; Chen X; Zhang J; Xu X
Clin Breast Cancer; 2023 Jun; 23(4):e219-e229. PubMed ID: 36890005
[TBL] [Abstract] [Full Text] [Related]
19. Combination of Anatomical and Biological Factors to Predict Disease-Free Survival in breast cancer.
Mohamed RF; Abdelhameed DH; Mohamed MA
JCO Glob Oncol; 2023 Mar; 9():e2200269. PubMed ID: 36888928
[TBL] [Abstract] [Full Text] [Related]
20. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
[TBL] [Abstract] [Full Text] [Related]
[Next]
